Associate Director, Blood Bank and Transfusion Medicine
Associate Medical Director of Blood Bank & Transfusion Service; Medical Director of Tissue Bank; Associate Program Director, Pathology Residency Program
Education and Training
2002 M.B.B.S. (Medical Degree), Medical College Baroda, Maharaja Sayajirao University of Baroda, India.
2003 M.Sc., Molecular Genetics, University of Leicester, U.K.
2010 Ph.D., Genetics, Pennsylvania State University, Thesis Advisor – Dr. Rebecca C. Craven.
2015 Residency, Clinical Pathology, Pennsylvania State University College of Medicine, Hershey, PA.
2016 Fellowship, Molecular Genetic Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.
2017 Fellowship, Blood Banking/Transfusion Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Clinically, I serve as the Associate Medical Director of the Blood Bank and Medical Director of Tissue Bank.
My research is focused on transfusion innovation: (a) performing in vitro functional analysis of blood products, and (b) collaborating on multi-center randomized controlled clinical studies.
I also focus on systems improvement projects related to (a) inventory management - to ensure availability of blood products when needed, while ensuring reduction in wastage; and (b) improving operational efficiency of the blood bank.
Transfusion Innovation, Clinical Trials, Inventory Management
- Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing.Transfusion. 2018 May;58(5):1126-1131. doi: 10.1111/trf.14550. Epub 2018 Feb 25.PMID: 29479708
- Solvent detergent treated pooled plasma and reduction of allergic transfusion reactions.Transfusion. 2020 Jan;60(1):54-61. doi: 10.1111/trf.15600. Epub 2019 Dec 16.PMID: 31840276
- Cryoprecipitated anti-hemophiliac factor manufactured from plasma frozen within 24 h after phlebotomy meets AABB quality standards. Transfusion. 2022 Sep;62(9):1731-1735. doi: 10.1111/trf.17032. Epub 2022 Jul 27.PMID: 35894539
- Algorithm-based selection of automated red blood cell exchange procedure goals reduces blood utilization in chronically transfused adults with sickle cell disease. J Clin Apher. 2022 Oct;37(5):468-475. doi: 10.1002/jca.22004. Epub 2022 Aug 22.PMID: 36053868 (*contributed equally).